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Background: Cigarette smoking has been associated with accelerated decline in lung function, increased
health services use and asthma severity in patients with asthma. Previous studies have provided insight into
how smoking cessation improves lung function among asthma patients, however, fail to provide measurable
asthma symptom-specific outcomes after smoking cessation. The objective of this study was to measure the
effect of changing smoking status on asthma symptom control and health services use in adults with asthma.
Methods: The study was conducted in eight primary care practices across Ontario, Canada participating in a
community-based, participatory, and evidence-based Asthma Care Program. Patients aged 18 to 55 identified
with physician-diagnosed mild to moderate asthma were recruited. In addition to receiving clinical asthma
care, participants were administered a questionnaire at baseline and 12-month follow-up visits to collect
information on demographics, smoking status, asthma symptoms and routine health services use. The effect of
changing smoking status on asthma symptom control was compared between smoking groups using
Chi-square and Fisher’s exact tests where appropriate. Mixed effect models were used to measure the impact
of the change in smoking status on asthma symptom and health services use while adjusting for covariates.
Results: This study included 519 patients with asthma; 11% of baseline smokers quit smoking while 4% of
baseline non-smokers started smoking by follow-up. Individuals who quit smoking had 80% lower odds of
having tightness in the chest (Odds ratio (OR) = 0.21, 95% CI: 0.06, 0.82) and 76% lower odds of night-time
symptoms (OR = 0.24, 95% CI: 0.07, 0.85) compared to smokers who continued to smoke. Compared to those
who remained non-smokers, those who had not been smoking at baseline but self-reported as current
smoker at follow-up had significantly higher odds of chest tightness (OR = 1.36, 95% CI: 1.10, 1.70), night-time
symptoms (OR = 1.55, 95% CI: 1.09, 2.20), having an asthma attack in the last six months (OR = 1.43, 95%
CI: 1.17, 1.75) and visiting a walk-in clinic for asthma (OR = 4.57, 95% CI: 1.44, 14.49).
Conclusions: This study provides practitioners measurable and clinically important findings that associate
smoking cessation with improved asthma control. Health practitioners and asthma programs can use powerful
education messages to emphasize the benefits of smoking cessation as a priority to current smokers.* Correspondence: teresa.to@sickkids.ca
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Smoking has been associated with accelerated decline in
lung function, increased health services use and asthma
severity in patients with asthma [1]. For these patients
that smoke, they experience worse control over their
asthma as compared with non-smokers with asthma [2].
Previously reported questionnaire and telephone surveys
of individuals with asthma provide conclusive evidence
that current smoking among asthma patients is asso-
ciated with a failure to obtain suitable levels of asthma
control [1-3]. In turn, smoking cessation among asthma
patients has led to improved lung function, reduced use
of β2-agonists, lower doses of inhaled corticosteroids
required, less frequent daytime asthma symptoms and
higher asthma-specific quality of life scores [4].
One study investigating the short-term effect of smok-
ing cessation on lung function, airway inflammation and
responsiveness in 20 smokers with asthma found that
those who quit smoking had achieved improvements in
lung function and reduction in sputum neutrophil by
6 weeks after they stopped smoking [5]. In a larger scale
study, involving 3,197 asthma patients, the effects of
inhaled corticosteroids on asthma symptom control were
lessened by cigarette smoking; highlighting the need to
place more emphasis on smoking cessation as part of
asthma education for patients to ensure treatment suc-
cess [6].
While these studies have provided insight into how
smoking cessation improves lung function among asthma
patients they fall short in providing asthma symptom-
specific outcomes after smoking cessation. Additionally,
there still remains little documented literature on the ef-
fect of smoking cessation on asthma symptom control
across a longitudinal period and among smokers. The aim
of this study was to measure the effect of changing smok-
ing status on asthma symptom control and health services
use in adults with asthma who participated in a comprehen-
sive evidence-based asthma program in order to provide
health care providers meaningful information pertinent to
educating patients with asthma who smoke.
Methods
Study setting
The Primary Care Asthma Pilot Project (PCAPP) was con-
ducted between January 2003 and May 2006 in the
province of Ontario, Canada, and has been previously
described [7,8]. In brief, the study was conducted in eight
primary care practices comprising 15 satellite clinics
across the largest province in Canada. These sites resided
in inner-city, urban and rural communities as well as one
isolated Northern Aboriginal community and provide pa-
tient care through multidisciplinary health care teams (in-
cluding general family practitioners, nurses and nurse
practitioners, medical residents and social workers). Thestudy methodology and materials were reviewed and
approved by the Research Ethics Board at The Hospital for
Sick Children Research Institute, Toronto, Ontario.
Study design and procedure
The study was a community-based participatory pre and
post design to evaluate implementation of the evidence-
based Asthma Care Program. This program is based on
asthma management standards developed by the Canadian
Thoracic Society Canadian Asthma Consensus Guidelines
[9-13] and consists of five components: 1) an asthma care
map; 2) a treatment flow chart; 3) program standards; 4) a
written asthma action plan; and 5) core elements of
asthma education. Prior to implementation, the asthma
care map was developed by the Ontario Thoracic Society,
as part of the Ontario Ministry of Health and Long-Term
Care’s Asthma Plan of Action, for use by a multi-disciplin-
ary team of primary health care providers as a template for
guideline-based management. It incorporates all elements
of the Canadian Asthma Consensus Guidelines, including
assessment and diagnosis, drug therapy and treatment
plan, action plan, patient education, and environmental
control.
A designated study coordinator (Certified Asthma
Educators, respiratory therapists or nurses with experi-
ence in asthma education) was assigned to each site and
was responsible for implementation of the Asthma Care
Program, performing spirometry, providing asthma edu-
cation to participants, coordinating program activities,
and recruiting participants. The study coordinators
approached patients aged 2 to 55 that were identified as
having been diagnosed with asthma by a physician to
participate in the study and then obtained consent.
Patients with unclear diagnosis of asthma, physician-
diagnosed Chronic Obstructive Pulmonary Disease (COPD)
or any of foreign body airway obstruction, congenital heart
disease, bronchopulmonary dysplasia, Alzheimer’s disease,
dementia, alcoholism or significant neurological deficit were
excluded.
In addition to the provision of clinical asthma care at
participants’ baseline and follow-up visit at 12-months, a
questionnaire was administered by the site study coord-
inator at both time points to collect demographic infor-
mation, smoking status, asthma symptoms, acute and
routine health services use, asthma management, and
medication use.
Independent variables
At baseline, demographic information was collected from
patients using the questionnaire and included date of
birth, gender, level of education, household income,
household size, and whether participants had a drug
benefit plan to pay for the cost of their asthma medica-
tions. Using household income and family size, a proxy
Figure 1 Number of individuals participating in study categorized
according to smoking status at baseline and follow-up.
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family of four or more with an annual income of less
than $40,000 (Canadian dollars) was defined as low SES
based on the 2002 before tax Low Income Cut-offs as
calculated by Statistics Canada [14].
Smoking status was defined by the participant response
to the following question that was asked to at the base-
line and 12-month follow-up visit, “At the present time,
do you smoke cigarettes?” The four groups of smoking
status were: 1) smokers (those who were current smokers
at both baseline and follow-up), 2) ex-smokers (those
who were smokers at baseline but not at follow-up), 3)
new smokers (those who were non-smokers at baseline but
were current smokers at follow-up), and 4) non-smokers
(those who were non-smokers at both baseline and follow-
up). Frequency of smoking (i.e. daily, weekly or less than a
week) was also collected, however, for the purpose of this
study any participant answering yes to the smoking status
question was considered to be smoking at that time irre-
spective of the frequency reported.
Outcome measures
At baseline and 12-month follow-up, self-reported data
on asthma symptom control and health services use were
collected. Asthma control was defined as the presence of
wheezing, shortness of breath, chest tightness and/or
cough, in the previous four weeks, daytime asthma
symptoms more than three times per week or night-time
symptoms one or more times per week, at least one
asthma exacerbation in the previous six months, and use
of asthma preventer medication in the previous six
months. Asthma health services use was defined as at
least one emergency department visit in the previous six
months and at least one urgent care visit (physician,
walk-in clinic or urgent care centre) in the previous six
months.
Statistical analysis
Only those aged 18 years and older (adults) were
included in this study for analysis. Baseline characteris-
tics including demographics, health status, and asthma
control of the four smoking status groups were com-
pared using Chi-square and Fisher’s exact tests where ap-
propriate. The statistical significance in the change of
asthma outcome measures (symptoms and health ser-
vices use) between baseline and 12-month follow-up was
measured by the McNemar’s test. Mixed effect models
were used to measure the impact of the change in
smoking status on asthma symptom and health ser-
vices use while adjusting for other covariates. Each
outcome measure at 12-month follow-up (listed above)
was modelled against its respective baseline measure
and adjusted for age and sex. The mixed effect mod-
els were repeated comparing smokers to ex-smokersand non-smokers to new smokers separately. Analyses
were performed using SAS version 9.1 (SAS Institute
Inc., Cary, NC).
Results
Study population baseline characteristics by smoking
status
A total of 733 participants aged 18 to 55 years were
recruited at baseline, and of those 519 (70.8%) who
had information on smoking status at both baseline
and 12-month follow-up. Figure 1 showed that of the
519 participants included in this study, 137 (26.4%)
were smokers at baseline. Amongst the baseline smo-
kers, most (n = 122, 89.1%) remained smokers, while
15 (10.9%) quit smoking at the 12-month follow-up
visit. Of the 382 baseline non-smokers, the majority
of them (n = 366, 95.8%) remained non-smokers, while
only a small proportion (n = 16, 4.2%) started smoking
by the 12-month follow-up visit. Among the baseline
smokers, those who remained smokers and those who
quit smoking at 12-months were not statistically dif-
ferent by demographic characteristics (Table 1). Base-
line non-smokers who became smokers at 12-months
were younger (35.3 ± 6.9 versus 40.8 ± 9.8, p = 0.007) and a
higher proportion with a drug plan (56.3% versus 22.9%,
p = 0.005) compared to subjects who remained non-
smokers.
Asthma symptoms at baseline and 12-month follow-up
Table 2 showed the percent distributions of asthma symp-
toms and health services use at baseline and 12-month fol-
low-up by smoking status. Overall, the ex-smokers showed
the biggest improvement in asthma symptom control over
time and had the lowest level of self-reported wheeze,
shortness of breath, tightness of chest and day-time symp-
toms amongst the four groups. Additionally, these indivi-
duals showed a significant decrease in shortness of breath,
Table 1 Demographic characteristics and smoking frequency at baseline/follow-up by smoking groups
Smokers Ex-smokers* Non-smokers New Smokers*
n % n % p-value n % n % p-value
Number of Patients 122 15 366 16
Baseline demographics
Age (Mean± SD) 39.13 ± 9.33 42.72 ± 8.10 0.128 40.82 ± 9.79 35.25 ± 6.93 0.007
Females 99 81.1 12 80.0 1.000 285 77.9 11 68.8 0.370
Residence 0.321 0.753
Urban Area 12 9.8 3 20.0 91 24.9 3 18.8
Rural Area 48 39.3 7 46.7 146 39.9 6 37.5
Inner City Area 62 50.8 5 33.3 129 35.2 7 43.8
Education (university/college or above) 44 36.1 5 33.3 0.818 248 67.8 10 62.5 0.660
Family Income≤ $40,000 13 10.7 0 0.0 0.360 36 9.8 2 12.5 0.667
Without a Drug Plan 36 29.5 4 26.7 0.942 83 22.9 9 56.3 0.005
Smoking Frequency at Baseline
Daily 113 92.6 10 n/a n/a
Weekly 2 1.6 1 n/a n/a
Less than once per week 7 5.7 4 n/a n/a
Smoking Frequency at 12-month Follow-up†
Daily 110 90.2 n/a n/a 11
Weekly 4 3.3 n/a n/a 2
Less than once per week 6 4.9 n/a n/a 3
*denotes smoking status at 12-month follow-up.
†missing data for 2 smokers at follow-up.
Abbreviations: SD, standard deviation; n/a, not applicable.
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their smoking counterparts at follow-up.
At 12-month follow-up, in general, the prevalence of
asthma symptoms (in last 4 weeks) lessened from baseline
in all four groups, except for the new smokers who experi-
enced slightly more day-time symptoms. At 12-month fol-
low-up, the level of wheeze (33.3% versus 66.4%,
p= 0.012), tightness in the chest (13.3% versus 60.7%,
p= 0.001), and night-time symptoms (13.3% versus 54.1%,
p= 0.003) in the ex-smokers were significantly lower when
compared to those who remained smokers. In contrast,
the levels of wheeze (81.3% versus 48.9%, p = 0.011) and
night-time symptoms (68.8% versus 40.2%, p = 0.023)
among the new smokers were significantly higher when
compared to those who remained non-smokers.
The percentage of individuals who had more than one
asthma attack in the last 6 months also decreased in all
four groups, with the ex-smokers showing almost 50%
decrease in 12 months.
Asthma health services use at baseline and 12-month
follow-up
At baseline and among the smokers, those who remained
smokers and those who quit smoking at 12-month follow-up were not statistically different except that ex-smokers
had almost 3 times higher urgent visits for asthma (33.3%
versus 12.3%, p = 0.045) and higher proportion of them
had peak flow monitoring (40.0% versus 16.5%, p = 0.04).
Among the non-smokers, the new smokers had a higher
percentage of school/work absenteeism at baseline (40.0%
versus 8.6%, p = 0.002).
The use of health services for asthma in the last
6 months was reported by the participants. While all
other groups had either no change or a decrease in
emergency department visits, the smokers had a five-fold
increase from baseline (from 1.6% to 8.2%, p = 0.0209).
The ex-smokers had the largest decrease in asthma
health services use, accompanied by a decrease in the
use of preventer and reliever medications; however, these
differences were not statistically significant.
Mixed effect models
Table 3 showed the impact of the change in smoking sta-
tus on asthma symptom and health services use analysed
using mixed effect models while adjusting for age, sex,
baseline symptoms and health services use. Individuals
who quit smoking had 80% lower odds of having tightness
in the chest (OR=0.21, 95% CI: 0.06, 0.82) and 76% lower
Table 2 Percent distributions of asthma symptoms and health services use at baseline and 12-month follow-up by smoking status
Baseline 12-Month Follow-up
Smokers Ex-Smokers p-value Non-Smokers New Smokers p-value Smokers Ex-Smokers p-value Non-Smokers New Smokers p-value
Number of Patients 122 15 366 16 122 15 366 16
Health Status
Fair-Poor Health rating 43.7 28.6 72.7 53.3 35.5 13.3 16.4 31.3
Less active 45.1 33.3 62.3 56.3 42.6 33.3 25.3 31.3
Asthma Control
Symptoms (last 4 weeks)
Wheeze 80.3 80.0 63.8 87.5 66.4 33.3 * 48.9 81.3 *
Shortness of Breath 82.0 66.7 76.8 93.8 63.9 53.3 60.4 75.0
Chest Tightness 77.1 53.3 68.0 81.3 60.7 13.3 ** 50.3 62.5
Cough 85.3 73.3 68.6 75.0 78.7 66.7 56.9 62.5
Night-time Symptoms 72.7 66.7 61.7 75.0 54.1 13.3 * 40.2 68.8 *
Day-time Symptoms 96.7 93.3 90.7 93.8 90.2 80.0 80.3 100.0
> 1 Asthma Attack in Last 6 months 81.7 61.5 79.3 76.9 63.9 33.3 56.6 60.0
Acute Health Services Use (last 6 months)
Any Urgent Visit 12.3 33.3 * 18.0 18.8 16.4 13.3 13.1 18.8
ER Visits 1.6 6.7 8.2 18.8 8.2 6.7 6.8 0.0
Walk-in Clinic Visits 11.5 26.7 12.9 0.0 8.2 13.3 7.1 18.8
School/Work Absenteeism (last 4 weeks)
Missed Work/School 18.5 30.8 8.6 40.0 * 10.7 0.0 10.1 13.3
Asthma Management
Received asthma education 43.4 33.3 39.9 43.8 24.8 13.3 23.2 62.5 *
Given an action plan 9.5 6.7 19.8 25.0 34.2 40.0 31.5 37.5
Regular peakflow monitoring 16.5 40.0 * 24.5 25.0 40.3 40.0 49.5 43.8
Spirometry 76.3 78.6 69.3 60.0 93.3 100.0 96.4 87.5
Medication Use
Preventer use 73.8 86.7 71.0 81.3 79.5 73.3 73.5 75.0




















Table 3 Mixed effect models to model impact of change



























> 1 Asthma Attack in last 6 months
Crude 0.52[0.23,1.18] 1.06[0.69,1.62]
Adjusted 0.56[0.22,1.39] 1.43[1.17,1.75]**














1Multivariable mixed effect models adjusted for age, sex, baseline symptoms
and health services use.* p<0.05, ** p<0.001.
NA, not available due to small sample size.
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0.85) compared to smokers who continued to smoke. On
the other hand, compared to the non-smokers, new smo-
kers had significantly higher odds of tightness in the chest
(OR=1.36, 95% CI: 1.10, 1.70), night-time symptoms
(OR=1.55, 95% CI: 1.09, 2.20), having an asthma attack in
the last 6 months (OR= 1.43, 95% CI: 1.17, 1.75) and
encountering a visit to the walk-in clinic for asthma
(OR= 4.57, 95% CI: 1.44, 14.49).
Discussion
This community-based participatory study evaluating the
effect of a change in smoking status on asthma symptom
control and health services use among adults living with
asthma over a 12 month period shows that asthma
patients who quit smoking experience significantly lower
(80%) night-time symptoms and chest tightness than
individuals who continue to smoke. In contrast, non-
smokers who took up smoking during follow-up had sig-
nificantly higher risks of asthma symptoms, 1.4-fold
higher risk of having asthma attacks and nearly 5-fold
risk of having visits to walk-in clinics for asthma.
It is important for health care providers to encourage
asthma patients who smoke to quit. The emphasis for
health care providers to take an active role and use strat-
egies to educate asthma patients about the benefits of
smoking cessation is well documented [15-17]. Unfortu-
nately, the success rates for smoking cessation in those
with asthma appears to be disappointingly low and evi-
dence on the effectiveness of smoking cessation in
asthma is rather limited [4-6]. Although health care pro-
viders may have tools to educate their patients about the
impact of quitting smoking, they may still be lacking
points of reference and achievable benefits of behav-
ioural change that can be discussed with patients. In
order to positively impact efforts of smoking cessation, a
system that supports both patients and their health care
team is required to successfully change patient behav-
iour. According to the Centers for Disease Control in the
US, [18] the majority of cigarette smokers quit without
using evidence-based cessation treatments. However,
there are other proven effective treatments: 1) brief clin-
ical interventions (i.e. when a doctor takes 10 minnutes
or less to deliver advice and assistance about quitting), 2)
counselling, 3) behavioural cessation therapies, 4) treat-
ments with more person-to-person contact and intensity,
and 5) cessation medications found to be effective for
treating tobacco dependence. To ensure the effectiveness
of these approaches, such a system should ideally facili-
tate health care providers to make referrals and to be
reimbursed accordingly for counselling. Furthermore,
such a system would ensure patients while quitting
smoking receive ongoing support in their routine asthma
care follow-up from health care providers.
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will experience improvement in lung function as early as
one week following smoking cessation with a further im-
provement up to six weeks after quitting, as shown by
Chaudhuri et al. [5]. However, patients may not associate
lung function improvement with “feeling better” and
having “well-controlled” asthma; instead, improvements
in asthma control may be more sought after. While we
did not have lung function data to indicate pulmonary
improvement, our asthma symptom control data pro-
vides similar positive evidence that smoking cessation is
significantly associated with lower asthma symptoms
within 12 months following cessation.
Our study findings offer health care providers measur-
able clinical benefits that can be imparted upon asthma
patients about the benefits of quitting smoking. An ex-
ample of a patient education message may include, “After
you have stopped smoking for 12 months, the odds of feel-
ing chest tightness is lowered by 80% and the risk of
night-time symptoms by 75% compared to an individual
who is still smoking.” It is equally important to emphasize
to current non-smokers that smoking is one of the signifi-
cant risk factors for asthma morbidity. Asthma patients
who are currently non-smokers should be encouraged to
remain so by their health care providers. For example,
communicate to non-smokers that, “If you start smoking,
your odds of wheezing will be increased by 30%, night-time
symptoms by 50% and having an asthma attack (within a
6-month period) by 40%”. Health care providers can con-
vey the clinical benefits or risks associated with asthma
and smoking to patients using such powerful and practical
messages.
There is a large body of literature suggesting different
methods to present treatment effects to patients that
may affect health care decisions. Previously, it has been
demonstrated that presenting benefits of specific treat-
ments or behaviour to patients as a relative risk reduction
with a comparator is a successful tactic [19]. Fagerlin
et al [20] found that providing average risk information
was valuable for physicians promoting patient behaviour
with smoking cessation. Our suggested messages to
health care providers agree with what was suggested in the
literature about using relative risk reduction information
and referencing it with a control comparator. Whether
over time this tactic yields affective change will have to be
demonstrated in a long-term follow-up study and is
beyond the scope of this current study. Interestingly,
we found that baseline non-smokers who were smok-
ing at 12-month follow-up had an odds ratio of 4.57
of a walk-in clinic visit compared to patients that
remained non-smokers. Previously, studies have found
that smoking was associated with a greater longitu-
dinal risk of hospitalization for asthma [21] and found
that persons who visited an emergency room forasthma in the past 12 months were 60% more likely
to be smokers [3].
While baseline smokers who quit by the 12-month
follow-up visit experience improvements in asthma
symptom control, individuals who continue to smoke
might not show improvement due to the use of inhaled
corticosteroids (ICS). Smokers with asthma compared
with non-smokers with asthma are less sensitive to the
short-term and medium-term effects of ICS on symp-
toms and lung function [22-24], suggesting that ICS
doses may need to be adjusted to attain asthma control
in smokers.
The approach used in our current study is novel. To
the best of our knowledge, the only published Canadian
study comparing adult asthma patients’ symptom control
among smoking status groups was based on a telephone
survey conducted by Boulet et al. [1]. The study assessed
self-reported asthma control and health services use
among individuals with asthma who were current smo-
kers, had quit smoking or were never smokers. Patients
with asthma who smoked were found to have worse con-
trol of their asthma than those who had stopped smok-
ing or who had never smoked. However, this study was
limited by the cross-sectional design and was unable to
measure changes in health outcomes associated with the
change in smoking status. In contrast, our study was a
community-based face-to-face prospective study where
asthma outcome measures were collected and assessed
by health care practitioners (family doctors, nurses and
asthma educators). The current study measured multiple
outcomes including asthma medication use, work/school
absenteeism, health status and asthma-related health ser-
vices use. Most previous published studies have mainly
focused on only one of these outcome measures [4,6,25].
Some limitations to the present study must be
noted. First, there is potential for smoking group mis-
classification due to categorization of smoking status
at baseline and 12-month follow-up. The “new smo-
kers” group may contain intermittent smokers should
individuals not be smoking for the first time. After
adjusting for age, sex, baseline symptoms and health
services use, the new smokers had significantly higher
odds of wheeze, chest tightness, night-time symptoms,
asthma attacks and walk-in clinic visits compared to
the non-smokers. Although not included in Table 3,
we also conducted comparisons between the new
smokers and all baseline smokers using multivariable
mixed effect analysis. If these new smokers were in-
deed intermittent smokers being misclassified as new
smokers, one would anticipate the odds ratios to be
closer to one. The odds of asthma outcomes while
lower were in fact similar to those between new smo-
kers and non-smokers reported in Table 3. While
there may be some level of potential misclassification,
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be completely explained by misclassification.
Since there may be important clinical differences be-
tween someone who stopped smoking a long time ago
versus someone who stopped recently, it would be help-
ful to know time of smoking cessation. Collecting smok-
ing history and more specifically, the number of packs of
cigarettes smoked by smokers, ex-smokers, new- and
intermittent smokers, would be useful. However, collect-
ing smoking history retrospectively may not be ideal as it
is prone to recall bias. The number of baseline non-
smokers who were former ex-smokers or never-smokers
may also influence significant findings; nevertheless, the
benefit of adding a ”former” or “never” smokers group is
limited by the number of individuals who fit the criteria.
Second, due to the design of the study, there is poten-
tial for interviewer bias. To avoid interviewer bias, one
may consider blinding the interviewer to the status of
the patients (case or control) which then would avoid
differential probing. In our study, however, it was im-
practical to blind the interviewers (nurses and asthma
educators) since these professionals recruited asthma
patients into the study. The smoking status of the
patients was, however, unknown to the interviewers prior
to the interview and the information about smoking was
collected after all other information was completed. In
our study, we used standardized questionnaires to collect
information on asthma symptoms, health services use
and smoking status. The interviewers were not allowed
to deviate from the scripts and thus, we did what was
possible in a community-based study.
Finally, additional information about lung function and
second-hand smoke was not included in the current
study. We did not collect lung function data such as pa-
tient spirometry tests, and therefore, could not adjust for
asthma severity when evaluating patients’ symptoms and
asthma control. However, our findings are consistent
with results reported by other studies that demonstrate
correlation between the improvement in lung function
measured objectively with “feeling better” after smoking
cessation [6]. Additionally, although we collected second-
hand smoke information in the current study, it was not
a variable accounted for in our findings. The absolute
number of subjects not exposed to second-hand smoke
in the ex-smokers group was 4, whereas it was 2 in the
new smokers group. We attempted to include the sec-
ond-hand smoke variable in our multivariable analysis,
however, the small numbers did not allow the model to
converge and we were not able to obtain the risk estimate
on smoking status. Incorporating these variables as cov-
ariates in future larger studies would be an asset. In the
current study, there were few individuals who changed
smoking status in a 12-month period and thus, there may
be a lack of power to detect an effect. A larger studywould need to be conducted in order to have adequate
power to adjust for the spectrum of asthma-related symp-
tom and exposure variables.
Conclusions
Our study provides measurable and clinically important
findings that associate smoking cessation among asthma
patients with improved asthma control. Asthma patients
who are going through smoking cessation may require on-
going counselling, support and review of personalized quit
plan. The monitoring of smoking cessation programs
should be integrated in the regular asthma follow-up care
patients receive by health practitioners. Additionally,
health care practitioners should closely monitor smoking
cessation to monitor and quantify the long-term effective-
ness of smoking cessation on asthma control. Further-
more, health practitioners and asthma programs can use
powerful education messages to emphasize the benefits of
smoking cessation as a priority to current smokers.
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